New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2012
13:20 EDTMAKOMAKO Surgical weakness a buying opportunity, says Piper Jaffray
Piper Jaffray views the weakness in shares of MAKO Surgical after Blue Belt's NavioPFS orthopedic surgery system received FDA approval as a buying opportunity. Piper thinks it will take time for NavioPFS to build momentum, but adds the approval means competition for MAKO in the U.S. The firm recommends buying shares on MAKO on today's weakness and reiterates an Overweight rating on the stock.
News For MAKO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for MAKO

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use